Center for Scientific Review; Notice of Closed Meetings, 9354-9356 [2021-02915]
Download as PDF
<![CDATA[
9354
Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices
• Preferred method: Submit
information through the Federal
eRulemaking Portal at https://
www.regulations.gov. Follow the online
instructions for submissions.
• Email: Send comments to
Paul.Rodriguez@hhs.gov with the
subject line ‘‘OMH AI/AN RFI: Center
for Indigenous Innovation and Health
Equity.’’
Submissions received after the deadline
will not be reviewed. Respond concisely
and in plain language. You may use any
structure or layout that presents your
information well. You may respond to
some or all of our questions, and you
can suggest other factors or relevant
questions. You may also include links to
online material or interactive
presentations. Clearly mark any
proprietary information and place it in
its own section or file. Your response
will become government property, and
we may publish some of its nonproprietary content.
FOR FURTHER INFORMATION CONTACT: Paul
Rodriguez, 1101 Wootton Parkway,
Suite 100, Rockville, MD 20852, (240)
453–8208, Paul.Rodriguez@hhs.gov.
SUPPLEMENTARY INFORMATION:
health, and the strongest predictors of
chronic disease, unintentional injury,
and premature death are linked to the
social determinants of health in AI/AN
communities.
Identification and awareness of health
outcomes and health determinants in
AI/AN populations are essential steps
towards reducing health disparities.1
Research has shown that communitydriven interventions have a positive
impact on health outcomes.2
The Office of Minority Health
Authorized under Section 1707 of the
Public Health Service Act, 42 U.S.C.
300u–6, as amended, the mission of
OMH is to improve the health of racial
and ethnic minority populations
through the development of health
policies and programs that help
eliminate health disparities. OMH
awards and other activities are intended
to support the identification of effective
policies, programs and practices for
improving health outcomes and to
promote sustainability and
dissemination of these approaches.
Under the authority of Public Law
116–260 (2021 Consolidated
Appropriations Act), Congress called for
the creation of a Center for Indigenous
Innovation and Health Equity to support
efforts including research, education,
service, and policy development related
to advancing Indigenous solutions to
decrease health disparities in the AI/AN
and NHPI populations.
Program Information
The purpose of this initiative is to
create a Center for Indigenous
Innovation and Health Equity (Center)
to provide services for American Indian
and Alaska Native and Native Hawaiian
and Pacific Islander populations that
draws on deeply-rooted indigenous
values and practices.
The Center should serve as a
coordinating entity that will partner
with accredited academic institutions
with a focus on Indigenous health
research, policy and innovation among
AI/AN and NHPI populations. The
Center will serve to build capacity and
to support efforts including research,
education, service, and policy
development related to advancing
Indigenous solutions. Work in these
areas will increase the capacity to
identify and address health disparities
in AI/AN and NHPI communities. The
Center is highly encouraged to engage
Indigenous leaders and community
partners to address AI/AN and NHPI
health disparities focus areas that align
with their goals and priorities. The
Center is expected to use a dual track
approach to address each populations’
needs and tailor indigenous knowledge
and practice specific to the AI/AN and
NPHI populations. Each track will be
parallel and complementary, both
rooted in indigenous values and
practices appropriate to each
population.
The Center’s objectives may include:
• Create an indigenous public health
agenda focused on research needs,
education, services, and health policies
to address AI/AN and NHPI health
disparities.
• Serve as a resource to support the
development, implementation,
Background
Heath disparities in the AI/AN
population in the United States include
higher rates of chronic diseases,
unintentional injuries and premature
deaths. The average life expectancy for
an AI/AN born today would be 4.4
fewer years than for an individual of
any other race. Empirical evidence
indicates that many factors influence
1 Centers for Disease Control and Prevention. CDC
Health Disparities and Inequalities Report—United
States, 2013. MMWR 2013;62 (Suppl 3). Retrieved
December 7, 2020 from https://www.cdc.gov/mmwr/
pdf/other/su6203.pdf.
2 O’Mara-Eves A., Brunton G., Oliver S.,
Kavanagh J., Jamal F., Thomas J. The effectiveness
of community engagement in public health
interventions for disadvantaged groups: A metaanalysis. BMC Public Health. 2015;15:129.
Published 2015 Feb 12. doi:10.1186/s12889–015–
1352–y.
I. Background Information
VerDate Sep<11>2014
17:27 Feb 11, 2021
Jkt 253001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
evaluation, dissemination, and
translation of evidence-based public
health interventions in AI/AN and NHPI
communities.
• Partner with academic institutions
and Indigenous leaders and community
partners in health disparities focus
areas.
• Train AI/AN and NHPI public
health, medical practitioners, students
and multi-sector partners.
The Center’s outcomes may include:
• Expand community capacity and
knowledge to develop evidence-based
program solutions, best practices and
policies that address health disparities
in AI/AN and NHPI populations.
• Increase utilizations of effective
strategies and tools to improve and
reduce AI/AN and NHPI health
disparities.
• Contribute to improved AI/AN and
NHPI health, elimination of health
disparities, and achievement of health
equity.
II. Request for Information
Through this RFI, OMH is seeking
information from the following entities:
Federally-recognized Indian Tribes/
American Indian and Alaska Native (AI/
AN) Tribes, Tribal organizations, Tribalserving organizations, Tribal Colleges
and Universities, and AI/AN-serving
institutions of higher education.
A separate RFI exists to solicit
feedback from Native Hawaiian and
Pacific Islander (NHPI) communities.
III. Questions
• How might the proposed Center
objectives and outcomes listed above
meet the needs of AI/AN populations?
• What is the recommended
composition and governance
infrastructure for the Center?
• Are there specific focus areas and
activities this center should address?
Dated: February 9, 2021.
Paul Rodriguez,
Senior Advisor for Operations, Office of
Minority Health.
[FR Doc. 2021–02953 Filed 2–11–21; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
E:\FR\FM\12FEN1.SGM
12FEN1
Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Clinical Neurophysiology, Devices,
Neuroprosthetics, and Biosensors.
Date: March 11–12, 2021.
Time: 8:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Cristina Backman, Ph.D.,
Scientific Review Officer, ETTN IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7846, Bethesda, MD 20892, (301) 480–
9069, cbackman@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Aging and Development, Auditory,
Vision and Low Vision Technologies.
Date: March 11–12, 2021.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Barbara Susanne Mallon,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–1042, mallonb@
mail.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Population and Public Health Approaches to
HIV/AIDS Study Section.
Date: March 11–12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, (301) 435–
1137, guerriej@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Interdisciplinary Clinical Care in Specialty
Care Settings Study Section.
Date: March 11–12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
VerDate Sep<11>2014
17:27 Feb 11, 2021
Jkt 253001
Contact Person: Abu Saleh Mohammad
Abdullah, Ph.D., Scientific Review Officer,
Center for Scientific Review, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 827–4043,
abuabdullah.abdullah@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; ImmunoOncology Research.
Date: March 11–12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mehrdad Mohseni, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7854, Bethesda, MD 20892, (301) 435–
0484, mohsenim@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Computational, Modeling and
Biodata Management.
Date: March 11, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, (301) 379–
9351, allen.richon@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Infectious
Diseases Clinical Research and Field Studies.
Date: March 11–12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tera Bounds, Ph.D., DVM,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, (301) 613–
2822, boundst@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biomedical Sensing, Measurement
and Instrumentation.
Date: March 11–12, 2021.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yordan V. Kostov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 867–5309, kostovyv@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Bacterial Pathogenesis.
Date: March 11, 2021.
Time: 9:30 a.m. to 6:00 p.m.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
9355
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard G. Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, (240) 519–
7808, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Brain Disorders and Related
Neurosciences.
Date: March 11–12, 2021.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vilen A. Movsesyan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M,
MSC 7806, Bethesda, MD 20892, (301) 402–
7278, movsesyanv@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Digestive
and Nutrient Physiology and Diseases.
Date: March 11–12, 2021.
Time: 9:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aster Juan, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20817, (301) 435–5000,
juana2@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
20–005: Transformative Research Award for
the INCLUDE Project (R01).
Date: March 11, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wenchi Liang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3150,
MSC 7770, Bethesda, MD 20892, (301) 435–
0681, liangw3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Interdisciplinary Clinical Care in Specialty
Care Settings.
Date: March 12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Chittari V. Shivakumar,
Ph.D., Scientific Review Officer, National
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Bethesda, MD
E:\FR\FM\12FEN1.SGM
12FEN1
9356
Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices
20892, (301) 408–9098, chittari.shivakumar@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
High Throughput Screening.
Date: March 12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Filpula, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181,
MSC 7892, Bethesda, MD 20892, (301) 435–
2902, filpuladr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–02915 Filed 2–11–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Allergy and Asthma
Statistical & Clinical Coordinating Center
(AA–SCCC).
Date: March 10, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G50,
Rockville, MD 20892 (Virtual Meeting).
VerDate Sep<11>2014
17:27 Feb 11, 2021
Jkt 253001
Contact Person: Louis A. Rosenthal, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health 5601
Fishers Lane, Room 3G50 Rockville, MD
20852, (240) 669–5070, rosenthalla@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–02916 Filed 2–11–21; 8:45 am]
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: February 8, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–02844 Filed 2–11–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
National Institute on Aging; Notice of
Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of Innovative Programs to
Enhance Research Training (IPERT)
Applications.
Date: March 19, 2021.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Rebecca H. Johnson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18C, 45 Center
Drive, Bethesda, MD 20892, 301–594–2771,
johnsonrh@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
PO 00000
Frm 00040
Fmt 4703
Sfmt 9990
Name of Committee: National Institute on
Aging Special Emphasis Panel; AD Model.
Date: March 9, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Nijaguna Prasad, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Gateway Building, Suite 2W200, Bethesda,
MD 20892, 301–496–9667, nijaguna.prasad@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: February 8, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–02843 Filed 2–11–21; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 86, Number 28 (Friday, February 12, 2021)]
[Notices]
[Pages 9354-9356]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02915]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
[[Page 9355]]
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Clinical Neurophysiology, Devices,
Neuroprosthetics, and Biosensors.
Date: March 11-12, 2021.
Time: 8:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Cristina Backman, Ph.D., Scientific Review
Officer, ETTN IRG, Center for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room 5211, MSC 7846, Bethesda, MD
20892, (301) 480-9069, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Aging and Development, Auditory, Vision and
Low Vision Technologies.
Date: March 11-12, 2021.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Barbara Susanne Mallon, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institute of Health,
6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1042,
[email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Population and Public Health Approaches to
HIV/AIDS Study Section.
Date: March 11-12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jose H. Guerrier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD
20892, (301) 435-1137, [email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Interdisciplinary Clinical Care in
Specialty Care Settings Study Section.
Date: March 11-12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Abu Saleh Mohammad Abdullah, Ph.D., Scientific
Review Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 827-4043, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Immuno-Oncology Research.
Date: March 11-12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mehrdad Mohseni, MD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5211, MSC 7854, Bethesda, MD 20892, (301) 435-
0484, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Computational, Modeling and Biodata
Management.
Date: March 11, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Allen Richon, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892, (301) 379-
9351, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Infectious Diseases Clinical Research and Field Studies.
Date: March 11-12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tera Bounds, Ph.D., DVM, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD
20892, (301) 613-2822, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Biomedical Sensing, Measurement and
Instrumentation.
Date: March 11-12, 2021.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yordan V. Kostov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20817, (301) 867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Bacterial Pathogenesis.
Date: March 11, 2021.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard G. Kostriken, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD
20892, (240) 519-7808, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Brain Disorders and Related Neurosciences.
Date: March 11-12, 2021.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vilen A. Movsesyan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M, MSC 7806, Bethesda, MD
20892, (301) 402-7278, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Digestive and Nutrient Physiology and Diseases.
Date: March 11-12, 2021.
Time: 9:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aster Juan, Scientific Review Officer, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20817, (301) 435-5000, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD-20-005: Transformative Research Award for the INCLUDE
Project (R01).
Date: March 11, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wenchi Liang, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3150, MSC 7770, Bethesda, MD 20892, (301) 435-
0681, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Interdisciplinary Clinical Care in Specialty Care Settings.
Date: March 12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Chittari V. Shivakumar, Ph.D., Scientific Review
Officer, National Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Bethesda, MD
[[Page 9356]]
20892, (301) 408-9098, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: High Throughput Screening.
Date: March 12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Filpula, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6181, MSC 7892, Bethesda, MD 20892, (301) 435-
2902, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-02915 Filed 2-11-21; 8:45 am]
BILLING CODE 4140-01-P
